Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Read our complete TB-500 guide
The SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events (MACE), marking a significant advancement in cardiometabolic care
GLP-1/GIP helps regulate appetite and food intake
Study 1 (ClinicalTrials.gov Identifier: NCT03548935) included 1961 patients with obesity or with overweight and at least 1 weight-related comorbid condition
Dont let expired medication become the pothole that derails your progress
These include: Enhanced glucose-dependent insulin secretion Suppressed glucagon secretion Slowed gastric emptying Increased satiety via central hypothalamic action This results in both glycaemic improvement and clinically meaningful weight loss
US$ 28.13
US$ 22.34
US$ 25.63
